ID

16012

Description

Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193011

Link

https://clinicaltrials.gov/show/NCT00193011

Keywords

  1. 5/2/16 5/2/16 -
  2. 6/26/16 6/26/16 -
Uploaded on

June 26, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00193011

Eligibility Breast Cancer NCT00193011

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
to be included in this study, you must meet the following criteria:
Description

Inclusion criteria

Data type

boolean

female patients with adenocarcinoma of the breast confirmed by biopsy
Description

female patients with adenocarcinoma of the breast

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0019638
UMLS CUI [1,3]
C0678222
age 65 or older
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
under age 65 must have significant medical illness, or general frailty
Description

significant medical illness

Data type

boolean

Alias
UMLS CUI [1,1]
C0205082
UMLS CUI [1,2]
C0221423
UMLS CUI [2]
C0424594
adequate bone marrow, liver or kidney function
Description

bone marrow, liver or kidney function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0232741
UMLS CUI [1,3]
C0232804
normal heart function
Description

cardiac function

Data type

boolean

Alias
UMLS CUI [1]
C0232164
less than 84 days from mastectomy/lumpectomy or axillary dissection
Description

time since surgery

Data type

boolean

Alias
UMLS CUI [1,1]
C1272706
UMLS CUI [1,2]
C3714726
signed consent obtained prior to initiation of any study procedures
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Description

Exclusion Criteria

Data type

boolean

received neo-adjuvant therapy
Description

Neoadjuvant Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0600558
primary tumor is locally advanced at diagnosis
Description

locally advanced tumor

Data type

boolean

Alias
UMLS CUI [1,1]
C0205179
UMLS CUI [1,2]
C0678222
received prior chemotherapy within five years
Description

prior chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1514457
received previous radiation therapy within 5 years
Description

previous radiation therapy

Data type

boolean

Alias
UMLS CUI [1]
C1522449
peripheral neuropathy
Description

Peripheral Neuropathy

Data type

boolean

Alias
UMLS CUI [1]
C0031117
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

ID.15

Data type

boolean

Similar models

Eligibility Breast Cancer NCT00193011

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Inclusion criteria
Item
to be included in this study, you must meet the following criteria:
boolean
female patients with adenocarcinoma of the breast
Item
female patients with adenocarcinoma of the breast confirmed by biopsy
boolean
C0079399 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
age
Item
age 65 or older
boolean
C0001779 (UMLS CUI [1])
significant medical illness
Item
under age 65 must have significant medical illness, or general frailty
boolean
C0205082 (UMLS CUI [1,1])
C0221423 (UMLS CUI [1,2])
C0424594 (UMLS CUI [2])
bone marrow, liver or kidney function
Item
adequate bone marrow, liver or kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
cardiac function
Item
normal heart function
boolean
C0232164 (UMLS CUI [1])
time since surgery
Item
less than 84 days from mastectomy/lumpectomy or axillary dissection
boolean
C1272706 (UMLS CUI [1,1])
C3714726 (UMLS CUI [1,2])
informed consent
Item
signed consent obtained prior to initiation of any study procedures
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Exclusion Criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
Neoadjuvant Therapy
Item
received neo-adjuvant therapy
boolean
C0600558 (UMLS CUI [1])
locally advanced tumor
Item
primary tumor is locally advanced at diagnosis
boolean
C0205179 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
prior chemotherapy
Item
received prior chemotherapy within five years
boolean
C1514457 (UMLS CUI [1])
previous radiation therapy
Item
received previous radiation therapy within 5 years
boolean
C1522449 (UMLS CUI [1])
Peripheral Neuropathy
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
ID.15
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial